BLACK SPADE ACQUISITION CO-A (BSAQ) Fundamental Analysis & Valuation

NYSEARCA:BSAQ • KYG115371000

Current stock price

10.45 USD
-4.37 (-29.49%)
At close:
11.23 USD
+0.78 (+7.46%)
After Hours:

This BSAQ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BSAQ Profitability Analysis

1.1 Basic Checks

  • BSAQ had positive earnings in the past year.
  • BSAQ had a negative operating cash flow in the past year.
BSAQ Yearly Net Income VS EBIT VS OCF VS FCFBSAQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 0 10M 20M

1.2 Ratios

Industry RankSector Rank
ROA 3.13%
ROE 3.32%
ROIC 13.41%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BSAQ Yearly ROA, ROE, ROICBSAQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 0 5 10

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for BSAQ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BSAQ Yearly Profit, Operating, Gross MarginsBSAQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BSAQ Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for BSAQ remains at a similar level compared to 1 year ago.
  • There is no outstanding debt for BSAQ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BSAQ Yearly Shares OutstandingBSAQ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M 20M
BSAQ Yearly Total Debt VS Total AssetsBSAQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M

2.2 Solvency

  • BSAQ has an Altman-Z score of 13.34. This indicates that BSAQ is financially healthy and has little risk of bankruptcy at the moment.
  • BSAQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.34
ROIC/WACCN/A
WACCN/A
BSAQ Yearly LT Debt VS Equity VS FCFBSAQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.17 indicates that BSAQ may have some problems paying its short term obligations.
  • BSAQ has a Quick Ratio of 0.17. This is a bad value and indicates that BSAQ is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
BSAQ Yearly Current Assets VS Current LiabilitesBSAQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BSAQ Growth Analysis

3.1 Past

  • BSAQ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.82%, which is quite impressive.
EPS 1Y (TTM)33.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. BSAQ Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 40.19, which means the current valuation is very expensive for BSAQ.
  • The average S&P500 Price/Earnings ratio is at 27.71. BSAQ is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 40.19
Fwd PE N/A
BSAQ Price Earnings VS Forward Price EarningsBSAQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BSAQ Per share dataBSAQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BSAQ Dividend Analysis

5.1 Amount

  • No dividends for BSAQ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BSAQ Fundamentals: All Metrics, Ratios and Statistics

BLACK SPADE ACQUISITION CO-A

NYSEARCA:BSAQ (8/14/2023, 8:04:01 PM)

After market: 11.23 +0.78 (+7.46%)

10.45

-4.37 (-29.49%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)02-15
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap220.76M
Revenue(TTM)N/A
Net Income(TTM)5.43M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 40.19
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.35
P/tB 1.35
EV/EBITDA N/A
EPS(TTM)0.26
EY2.49%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS7.74
TBVpS7.74
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 3.13%
ROE 3.32%
ROCE N/A
ROIC 13.41%
ROICexc 13.43%
ROICexgc 13.43%
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z 13.34
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y379.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-165.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-165.34%
OCF growth 3YN/A
OCF growth 5YN/A

BLACK SPADE ACQUISITION CO-A / BSAQ Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BLACK SPADE ACQUISITION CO-A (BSAQ) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BSAQ.


Can you provide the valuation status for BLACK SPADE ACQUISITION CO-A?

ChartMill assigns a valuation rating of 0 / 10 to BLACK SPADE ACQUISITION CO-A (BSAQ). This can be considered as Overvalued.


What is the profitability of BSAQ stock?

BLACK SPADE ACQUISITION CO-A (BSAQ) has a profitability rating of 0 / 10.


What is the financial health of BLACK SPADE ACQUISITION CO-A (BSAQ) stock?

The financial health rating of BLACK SPADE ACQUISITION CO-A (BSAQ) is 5 / 10.